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Congenital adrenal hyperplasia (CAH) refers to
autosomal recessive diseases resulting from deficiency
of enzymes involved in the production of cortisol by the
adrenal glands. More than 90% of cases of CAH are
caused by 21-hydroxylase enzyme deficiency (21-OHD).
Neonatal screening program for blood 17-hydroxy-
progesterone (OHP) levels are intended to identify CAH
cases of classical and non-classical forms in affected
children before the complication of salt wasting crises
arises and for early diagnosis of late non-specific
presentation, respectively. Screening of non-classical
CAH through testing blood (17-OHP) levels is the
cornerstone for early diagnosis as disease presentation
is non-specific as well as late in onset. Levels of 17-OHP
> 4 ng/ml is a characteristic feature for disease suspicion
in non classical form in contrast to the diagnostic levels
of 200 ng/ml  in classical form of CAH.1
The non-classic form is one of the most common
autosomal recessive diseases in some ethnic groups
and one of the reasons of high prevalence of CAH
throughout the world.
The objective of this study was to determine the
frequency of raised 17-OHP among different age groups
and gender by evaluating the laboratory data of baseline
blood 17-OHP levels.
This observational retrospective study was conducted at
Chemical Pathology Section, Department of Pathology
of the Aga Khan University Hospital (AKUH). Laboratory
data of 5853 samples tested for blood 17-OHP levels
was examined. The samples were collected between
2007 to 2010, at the main laboratory of AKUH in Karachi
and its 188 phlebotomy centres located in four provinces
of Pakistan. Subjects of all ages and gender with first
time and baseline 17-OHP blood levels performed at the
clinical laboratory were included. Those with any
follow-up blood 17-OHP levels or stimulated with
adrenocorticotropic hormone were excluded. 17-OHP
results were grouped on the basis of locations of
subjects, from where the test was ordered into Sindh,
Baluchistan, Punjab and Khyber Pakhtunkhwa (KPK).
Subjects were further categorized into four different age
groups and three gender groups and frequency was
observed for each age group and gender.
The study was approved by institutional ethical review
committee. Analysis of 17-OHP concentrations was
made with radioimmunoassay using Coat-A-Count kit
(Diagnostic Product Corporation, USA). The assay
sensitivity of 17-OHP was 0.1 ng/ml and intra- and inter-
assay CVs were 7.9 and 12%, respectively. The 17-OHP
value of ≥ 4 ng/ml was considered consistent with
21-OHD enzyme deficiency or suspected CAH.2 Data
was edited and analyzed by using Statistical Package
for Social Sciences (SPSS) version 19. Frequencies
were measured for age groups, gender and distribution
of suspected subjects with CAH among four provinces of
Pakistan. Chi-square or Fisher exact test used where
applicable, p-value < 0.05 was considered significant.
There was an annual increasing frequency of blood 17-
OHP levels screening (16.3%, 16.9%, 20.4% and 46.4%
through the years from 2007 to 2010 respectively). An
increasing annual trend, for frequency of subjects with
suspected CAH (blood 17-OHP levels ≥ 4 ng/ml) as
5.1%, 6.5%, 7.1% and 15.7% respectively through the
years 2007 to 2010. In general, screening for CAH was
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performed for different age group and gender. However,
first time screening was predominantly performed in
female population and after 15 years.
Overall, 34.4% subjects with suspicion of CAH were
observed to have 17-OHP blood levels ≥ 4 ng/ml.
Majority of subjects with 17-OHP levels ≥ 4 ng/ml were
from infant age group (≥ 1 month to ≤ 1 year). Mostly
females were found positive for suspicion of CAH
(p < 0.001). Variable percentages were observed for
referrals of 17-OHP levels from different provinces but
majority were referred from Sindh (73.4%). The
demographic details of the subjects are shown in
Table I.
In Pakistan, the data on CAH is very limited. The
features reported from previous studies were about the
complications due to delay in diagnosis and high degree
of consanguinity and infertility in local population.
However, none of the study determined the disease
burden though expected to be high due to the high
frequency of parental consanguinity.3
Most of the suspected cases were infants (14.4%),
reflecting the importance of neonatal screening.
However, it was observed that CAH screening was most
commonly ordered in elder age group (after 15 years).
This late screening may be explained by the late
emergence of non-classical CAH signs and symptoms.
Variable frequency of referrals from different provinces
of Pakistan was observed as shown in Table I. Higher
frequency of cases with suspected CAH was observed
from Sindh (23.7%) as compared to other provinces.
The most likely reason of this higher frequency from
Sindh may be dependent on numbers of referrals or the
number of collection centres from the province (73.4%).
In Sindh, 68% of the samples were collected from the
(78) phlebotomy centres in Karachi and the main AKU
Campus. An additional 5.4% of samples from other
phlebotomy centres located in different cities of Sindh
other than Karachi, but we found Karachi city as the
main hub for 17-OHP referrals from Sindh province
which may be due to the large number of phlebotomy
centres in the area. From this laboratory data it is not
possible to determine the ethinicity of suspected CAH
cases, but it could be presumed that CAH exists
throughout the country with variable frequency. This
finding is also supported by the results of a previous
study from Pakistan.4
The importance of establishing neonatal screening
program for CAH is enhanced by the present data;
however, the benefits of screening for any disease in a
state are dependent on the existing healthcare system.
The treatment or management of inborn disorders has
not been acknowledged appropriately in Pakistan.
Additionally, the existing healthcare system generally
does not address complex issues commonly seen in
genetic disorders including CAH patients.5
The true incidence of CAH in Pakistan remains
unidentified due to the absence of new born screening
program, diagnostic testing, and lack of disease aware-
ness in the society and failure of case identification by
primary physicians. There is a need for developing a
team of experts in early identification and management
of CAH to reduce the morbidity and mortality. A well
structured and appropriate screening program should be
instituted for the high risk groups and the general
population. The establishment of CAH registry is also
critical at regional or national levels for the identified
cases and respective pre-natal treatment.
REFERENCES
1. Aziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L,
Boots LR. Screening for 21-hydroxylase-deficient non-classic
adrenal hyperplasia among hyperandrogenic women: a
prospective study. Fertil Steril 1999; 72:915-25. 
2. Bhanji R, Khan AH, Balouch IL, Sabir S, Nazir Z, Billoo AG.
Profile of children with congenital adrenal hyperplasia: a hospital
study. J Pak Med Assoc 2004; 54:509-12. 
3. White PC, Speiser PW. Congenital adrenal hyperplasia due to
21-hydroxylase deficiency. Endocr Rev 2000; 21:245-91. Epub
17 Jun 2000.
4. Khan AH, Aban M, Rameez ul H, Naeem ul H, Raza J, Jabbar A,
et al. Classic virilizing congenital adrenal hyperplasia presenting
late: case series from Pakistan. J Pak Med Assoc 2009; 59:
643-6. 
5. Satwani H, Raza J, Hanai J, Nomachi S. Prevalence of selected
disorders of inborn errors of metabolism in suspected cases at a
tertiary care hospital in Karachi. J Pak Med Assoc 2009; 59:
815-9. 
Table I: Demographic features and distribution of subjects among
different provinces of Pakistan tested for blood 17-OHP
levels at the Aga Khan University, Clinical Laboratory during
2007 - 2010 (n = 2282).
Variables Total subjects 17-OHP levels  *p-value
≥ 4 ng/ml
n = 2282 (%) n = 784 (34.4%) 
Age groups 
Up to 1 month 32 (1.4) 28 (1.2) 0.0001
> 1 month  to ≤ 1 year 477 (20.9) 328 (14.4)
> 1 year to ≤ 15 years 758 (33.2) 278 (12.2)
> 15 years 1015 (44.5) 150 (6.6) 
Gender 
Male 756 (33.1) 363 (15.9) 0.0001
Female 1520 (66.6) 416 (18.2)
Ambiguous 6 (0.3) 5 (0.2)
Subjects  distribution 
within  country
Sindh 1676 (73.4) 541 (23.7) 0.108
Punjab 524 (23.0) 209 (9.2)
Baluchistan 9 (0.4) 3 (0.1)
KPK 73 (3.2) 31 (1.4) 
*p-value < 0.05 is considered as significant
